George Magel, MD
Dermatology · Hickory, NCNPI 1265768485
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $443,906 of the $554,233 with a category attached, or 80.1%. 41 manufacturers reported payments, led by Johnson & Johnson at 44.9% of the total. 2025 is the largest year on record at $140,717, 2.7 times the $51,965 reported in 2019. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,012 payments — averaging $547.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$249K
- Janssen Scientific Affairs, LLC$159K
- AbbVie$134K
- Merz North America, Inc.$2K
- Journey Medical Corporation$1K
- Pfizer$1K
- plus $8K from 35 others
What the payments were for
- Consulting fees$30,4635%
- Speaking & faculty fees$443,90680%
- Travel & lodging$55,74010%
- Food & beverage$23,5914%
- Education$5330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$554,233 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $204,351 |
| Fluorouracil | 45 | $3,350 |
| Triamcinolone Acetonide | 160 | $2,123 |
| Clobetasol Propionate | 49 | $1,647 |
| ValacyclovirValacyclovir Hcl | 47 | $1,553 |
| Clindamycin Phosphate | 41 | $1,547 |
| Ketoconazole | 97 | $1,434 |
| Doxycycline Hyclate | 63 | $790 |
| Desonide | 12 | $603 |
| Hydroxychloroquine Sulfate | 12 | $281 |
| Mupirocin | 37 | $276 |
| Ammonium Lactate | 17 | $269 |
| Terbinafine Hcl | 12 | $104 |
| Cephalexin | 11 | $99 |
| Prednisone | 21 | $86 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hickory
- Jake TurrentineHickory$154K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
- Rosalyn GeorgeWilmington$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.